On November 10th of last year, RudaCure was finally selected for the 韩国健康产业振兴院's Early 初创企业 Package Support Project and will receive support for the commercialization of RCI001 until May 2021.
Through this project, the company will more thoroughly prepare for 临床试验 and lay the groundwork for FDA 临床试验.